Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Ophthalmology

19-ENT-4286-NewFacialCenter-650×450

Center Provides Hope for Patients With Facial Deformity and Paralysis

Collaboration is key to expanding access for patients

Redness in the eye caused by anterior chamber inflammation
January 6, 2020/Ophthalmology

Can Patient-Reported Measures Aid Assessment of Disease Activity in Inflammatory Eye Disease?

Study assesses utility of patient-reported outcomes measures in uveitis and scleritis

This color fundus photo of the clinical presentation of a left eye affected by radiation retinopathy shows multiple retinal exudates (yellow material) surrounding the irradiated tumor. Copyright image used with permission from Elsevir.
November 15, 2019/Cancer

Creating a First-Ever Animal Model of Brachytherapy-Induced Radiation Retinopathy

First step toward testing therapeutics

19-EYE-4245-Non-Proliferative-Diabetic-Retinopathy-CQD

Anti-VEGF Therapy Effective in Treating High-Risk Nonproliferative Diabetic Retinopathy Without Diabetic Macular Edema

Significant reduction in risk for vision loss and disease progression

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-EYE-4244-Talcott-CQD-Hero

Novel Image Analysis Platform May Detect Early Signs of Retinal Toxicity Secondary to Hydroxychloroquine Use

Research shows ellipsoid zone mapping’s potential

19-EYE-4256-Keratoconus-Randleman-CQD

Focusing on Corneal Ectatic Disease: An In-Depth Conversation with J. Bradley Randleman, MD

Brillouin imaging, corneal cross-linking could aid identification and management of keratoconus and postoperative ectasia

650×450-Traboulsi
July 26, 2019/Ophthalmology

Outcomes of Unilateral Cataract Surgery in Infants and Toddlers With Aphakia and Pseudophakia

Unilateral cataract surgery appears relatively safe for children aged 7-24 months

Macular degeneration

Brolucizumab Delivers Superior Elimination of Retinal Fluid and Possibly Reduced Dosing Frequency than Aflibercept in Two Studies

Greater durability of action also allows spacing of doses

NEI ROP

The HIF Stabilizer Roxadustat Doesn’t Lead to Pathological Retinal Angiogenesis

New research sheds light on mechanism of action in ROP protection

18-EYE-4345-Dupps-CQD-Feat

Treating Progressive Keratoconus: Going Beyond Disease Stabilization

Combined transepithelial PTK, CXL yields improvements

BackPage 13 of 16Next

Advertisement

Ad